200 related articles for article (PubMed ID: 18179673)
1. Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population.
Guo JJ; Keck PE; Li H; Jang R; Kelton CM
Value Health; 2008; 11(3):416-23. PubMed ID: 18179673
[TBL] [Abstract][Full Text] [Related]
2. Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder.
Guo JJ; Keck PE; Li H; Patel NC
Psychiatr Serv; 2007 Aug; 58(8):1073-8. PubMed ID: 17664518
[TBL] [Abstract][Full Text] [Related]
3. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
4. Employee costs before and after treatment initiation for bipolar disorder.
Brook RA; Kleinman NL; Rajagopalan K
Am J Manag Care; 2007 Apr; 13(4):179-86. PubMed ID: 17408337
[TBL] [Abstract][Full Text] [Related]
5. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
Stensland MD; Jacobson JG; Nyhuis A
J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
[TBL] [Abstract][Full Text] [Related]
6. Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder.
Rajagopalan K; Kleinman NL; Brook RA; Gardner HH; Brizee TJ; Smeeding JE
Curr Med Res Opin; 2006 Mar; 22(3):443-52. PubMed ID: 16574028
[TBL] [Abstract][Full Text] [Related]
7. Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a Medicaid programme.
Qiu Y; Fu AZ; Liu GG; Christensen DB
Appl Health Econ Health Policy; 2010; 8(3):167-77. PubMed ID: 20408601
[TBL] [Abstract][Full Text] [Related]
8. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
9. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
10. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
McCombs JS; Ahn J; Tencer T; Shi L
J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
[TBL] [Abstract][Full Text] [Related]
11. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
Centorrino F; Mark TL; Talamo A; Oh K; Chang J
J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
[TBL] [Abstract][Full Text] [Related]
12. Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population.
Harley C; Li H; Corey-Lisle P; L'Italien GJ; Carson W
Soc Psychiatry Psychiatr Epidemiol; 2007 Sep; 42(9):690-7. PubMed ID: 17603740
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
Davis KL; Candrilli SD; Edin HM
Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
[TBL] [Abstract][Full Text] [Related]
14. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
[TBL] [Abstract][Full Text] [Related]
15. Acute inpatient treatment, hospitalization course and direct costs in bipolar patients with intellectual disability.
Wu CS; Desarkar P; Palucka A; Lunsky Y; Liu SK
Res Dev Disabil; 2013 Nov; 34(11):4062-72. PubMed ID: 24051362
[TBL] [Abstract][Full Text] [Related]
16. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
17. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
18. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
19. Cost of atrial fibrillation in United States managed care organizations.
Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
[TBL] [Abstract][Full Text] [Related]
20. In-patient care costs of patients with bipolar I disorder: a comparison between two European centers.
Gonzalez-Pinto AM; Dardennes R; de Zélicourt M; López P; Oliveros RG; Vieta E; Barbeito S; Echevarria E; Fagnani F
J Affect Disord; 2010 Feb; 121(1-2):152-5. PubMed ID: 19482360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
